Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Many of these GLP-1 and GLP-1/GIP receptor agonists were initially developed to treat type 2 diabetes. However, an unexpected side effect was noticed: people taking these medications began losing ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

The drug semaglutide, commonly known by the brand names Ozempic or Wegovy, was originally developed to help people with type 2 diabetes manage their ...

The effect is partly due to the drug’s influence on the ... This makes it beneficial for people with diabetes or those at ...

Last week, we were excited to announce the nomination of our first smart GIP/GLP-1 pancreatic gene therapy lead candidate ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

Stroke survivors who took GLP-1 or SGLT2 medications had a 74% lower risk of death ... based Mayo Clinic researchers analyzed the effect GLP-1s and SGLT2s medications had on stroke survivors' risk of ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...